Response to imatinib rechallenge in a patient with a recurrent gastrointestinal stromal tumor after adjuvant therapy: a case report

INTRODUCTION: Adjuvant imatinib improves recurrence-free survival of patients following resection of primary KIT-positive gastrointestinal stromal tumors. However, it is unknown whether patients who previously received adjuvant imatinib therapy will respond to imatinib rechallenge as treatment for r...

Descripción completa

Detalles Bibliográficos
Autor principal: Kang, Yoon-Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212843/
https://www.ncbi.nlm.nih.gov/pubmed/21975443
http://dx.doi.org/10.1186/1752-1947-5-504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212843/
https://www.ncbi.nlm.nih.gov/pubmed/21975443
http://dx.doi.org/10.1186/1752-1947-5-504

Ejemplares similares